UNIVERSITY OF UTAH

🇺🇸United States

Country: 🇺🇸United States

Ownership: Private

Established: 1850-02-28

Employees: 10K

Market Cap: -

Website: http://www.utah.edu

Clinical Trials

PCSK9 Inhibition in Patients With Symptomatic Intracranial Atherosclerosis

Early Phase 1

Terminated

Conditions: Stroke
Intracranial Atherosclerosis
Intraplaque Hemorrhage

Interventions: Drug: Placebo
Drug: Alirocumab

First Posted Date: 2018-04-25

Last Posted Date: 2020-04-21

Lead Sponsor: University of Utah

Target Recruit Count: 20

Registration Number: NCT03507374

Locations: 🇺🇸
University of Utah, Salt Lake City, Utah, United States

Cryoballoon Targeting Atrial Fibrosis in Atrial Fibrillation

Not Applicable

Withdrawn

Conditions: Atrial Fibrillation
Left Atrial Fibrosis

First Posted Date: 2018-04-05

Last Posted Date: 2019-07-19

Lead Sponsor: University of Utah

Registration Number: NCT03489096

Incidence of Diarrhea Using High and Low Osmolality Enteral Tube Feeding in Critically Ill Surgical Patients

Not Applicable

Terminated

Conditions: Tube Feeding

Interventions: Other: Osmolite 1.5
Other: Promote without fiber

First Posted Date: 2018-04-04

Last Posted Date: 2019-07-23

Lead Sponsor: University of Utah

Target Recruit Count: 60

Registration Number: NCT03487744

Locations: 🇺🇸
University of Utah Health, Salt Lake City, Utah, United States

Enriching Clinical Trials Requiring Amyloid Positivity With Practice Effects

Completed

Conditions: Mild Cognitive Impairment
Alzheimer Disease

Interventions: Diagnostic Test: [18F]flutemetamol PET scan

First Posted Date: 2018-03-15

Last Posted Date: 2023-04-28

Lead Sponsor: University of Utah

Target Recruit Count: 165

Registration Number: NCT03466736

Locations: 🇺🇸
University of Utah, Salt Lake City, Utah, United States

Dissecting De-automatization

Not Applicable

Completed

Conditions: Mindfulness

Interventions: Behavioral: Active Listening
Behavioral: Mindfulness Meditation Training

First Posted Date: 2018-03-07

Last Posted Date: 2018-10-01

Lead Sponsor: University of Utah

Target Recruit Count: 53

Registration Number: NCT03456505

Locations: 🇺🇸
University of Utah, Salt Lake City, Utah, United States

Game-Based Decision Aid to Educate Pregnant Women About Prenatal Screening

Not Applicable

Completed

Conditions: Prenatal Disorder

Interventions: Behavioral: Meaning of Screening

First Posted Date: 2018-02-22

Last Posted Date: 2018-02-26

Lead Sponsor: University of Utah

Target Recruit Count: 79

Registration Number: NCT03441672

Fatigue Interventions in Cancer (Exercise Intervention)

Phase 2

Completed

Conditions: Sedentary Lifestyle
Stage IV Prostate Cancer AJCC v7
Stage III Prostate Cancer AJCC v7

Interventions: Behavioral: Cognitive Behavior Therapy
Behavioral: Exercise Intervention

First Posted Date: 2018-02-05

Last Posted Date: 2024-03-20

Lead Sponsor: University of Utah

Target Recruit Count: 126

Registration Number: NCT03421782

Locations: 🇺🇸
Huntsman Cancer Institute/University of Utah, Salt Lake City, Utah, United States

Short Course Vaginal Cuff Brachytherapy in Treating Participants With Stage I-II Endometrial Cancer

Phase 3

Recruiting

Conditions: Endometrial Clear Cell Adenocarcinoma
Uterine Corpus Carcinosarcoma
Stage I Uterine Corpus Cancer
Endometrial Endometrioid Adenocarcinoma
Stage IB Uterine Corpus Cancer
Uterine Corpus Sarcoma
Endometrial Serous Adenocarcinoma
Stage IA Uterine Corpus Cancer
Stage II Uterine Corpus Cancer

Interventions: Radiation: Short course vaginal cuff brachytherapy
Radiation: Vaginal Cuff Brachytherapy

First Posted Date: 2018-02-05

Last Posted Date: 2024-08-28

Lead Sponsor: University of Utah

Target Recruit Count: 188

Registration Number: NCT03422198

Locations: 🇺🇸
MD Anderson, Houston, Texas, United States
🇺🇸
Huntsman Cancer Institute/University of Utah, Salt Lake City, Utah, United States
🇺🇸
Stanford Cancer Center, Palo Alto, California, United States

and more 2 locations

Hyperhidrosis, Developing a Treatment Approach Aims 1 & 2

Phase 1

Completed

Conditions: Hyperhidrosis

Interventions: Drug: Aluminum Chloride 20% (deodorant)
Drug: Alcohol

First Posted Date: 2018-01-31

Last Posted Date: 2022-10-17

Lead Sponsor: University of Utah

Target Recruit Count: 95

Registration Number: NCT03416348

Locations: 🇺🇸
George E. Wahlen Department of Veterans Affairs Medical Center, Salt Lake City, Utah, United States
🇺🇸
University of Utah, Salt Lake City, Utah, United States

Apatinib With Pembrolizumab in Previously Treated Advanced Malignancies

Phase 1

Terminated

Conditions: Advanced Malignancies
MSI-H or dMMR Solid Tumors
Urothelial Carcinoma
Gastric or Gastroesophageal Junction (GEJ) Adenocarcinoma

Interventions: Drug: Apatinib
Drug: Pembrolizumab

First Posted Date: 2018-01-23

Last Posted Date: 2020-07-15

Lead Sponsor: University of Utah

Target Recruit Count: 5

Registration Number: NCT03407976

Locations: 🇺🇸
Huntsman Cancer Institute, Salt Lake City, Utah, United States

© Copyright 2025. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy